ADMA Biologics ADMA Issuance of warrants
Issuance of warrants at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued.
The official record: ADMA Biologics’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's issuance of warrants.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ADMA Biologics's issuance of warrants?
- ADMA Biologics (ADMA) reported issuance of warrants of $1.4M in Q4 2023.
- What does issuance of warrants mean?
- This represents changes to additional paid-in capital resulting from the issuance of warrants. It reflects the equity impact of granting rights to purchase shares at a future date, often used as part of financing or incentive arrangements.